BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2835972)

  • 1. Dibutyryl cAMP inhibits expression of transformation-related properties in Kirsten murine sarcoma virus transformed Balb/c-3T3 cells despite continued presence of p21v-Ki-ras.
    Ridgway AA; De Vouge MW; Mukherjee BB
    Biochem Cell Biol; 1988 Jan; 66(1):54-65. PubMed ID: 2835972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP-independent processes mediate Kirsten sarcoma virus-induced changes in collagen production and other properties of cultured cells.
    Majmudar G; Peterkofsky B
    J Cell Physiol; 1985 Jan; 122(1):113-9. PubMed ID: 2578130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
    Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
    Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction of the rat-specific RNS sequences of Ki-MSV to the nucleus of dibutyryl cyclic AMP-treated K-A31 cells.
    Ridgway AA; Mukherjee BB
    J Gen Virol; 1980 Oct; 50(2):391-401. PubMed ID: 6161990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Kirsten murine sarcoma virus transformation-induced changes in the collagen phenotype and synthetic rate of BALB 3T3 cells.
    Bateman JF; Peterkofsky B
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6028-32. PubMed ID: 6273840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct identification of palmitic acid as the lipid attached to p21ras.
    Buss JE; Sefton BM
    Mol Cell Biol; 1986 Jan; 6(1):116-22. PubMed ID: 3023817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ras oncogene activates the intracisternal A particle long terminal repeat promoter through a c-AMP response element.
    Galien R; Mercier G; Garcette M; Emanoil-Ravier R
    Oncogene; 1991 May; 6(5):849-55. PubMed ID: 1828874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of viral p21ras during acquisition of a transformed phenotype by rat adrenal cortex cells infected with Kirsten murine sarcoma virus.
    MacAuley A; Auersperg N; Pawson T
    Mol Cell Biol; 1986 Jan; 6(1):342-6. PubMed ID: 3023835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine sarcoma virus.
    Tsuchida N; Ryder T; Ohtsubo E
    Science; 1982 Sep; 217(4563):937-9. PubMed ID: 6287573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of a Kirsten murine sarcoma virus ras oncogene in cells transformed by 3-methylcholanthrene.
    Parada LF; Weinberg RA
    Mol Cell Biol; 1983 Dec; 3(12):2298-301. PubMed ID: 6197628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.
    Norton JD; Cook F; Roberts PC; Clewley JP; Avery RJ
    J Virol; 1984 May; 50(2):439-44. PubMed ID: 6323744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbate-independent proline hydroxylation resulting from viral transformation of Balb 3T3 cells and unaffected by dibutyryl cAMP treatment.
    Evans CA; Peterkofsky B
    J Cell Physiol; 1976 Nov; 89(3):355-67. PubMed ID: 185226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning of the temperature-sensitive 371 Kirsten murine sarcoma virus and expression in Escherichia coli of the mutant and wild-type viral Kirsten ras p21 proteins.
    Stein RB; Tai JY; Scolnick EM
    J Virol; 1986 Nov; 60(2):782-6. PubMed ID: 3022010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression.
    Radinsky R; Culp LA
    Int J Cancer; 1991 Apr; 48(1):148-59. PubMed ID: 2019453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The viral Ki-ras gene must be expressed in the G2 phase if ts Kirsten sarcoma virus-infected NRK cells are to proliferate in serum-free medium.
    Durkin JP; Whitfield JF
    Mol Cell Biol; 1987 Jan; 7(1):444-9. PubMed ID: 3031473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the onc gene of the Kirsten murine sarcoma virus in differentiated rat thyroid epithelial cell lines.
    Ferrentino M; Di Fiore PP; Fusco A; Colletta G; Pinto A; Vecchio G
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1955-61. PubMed ID: 6094710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.
    MacAuley A; Pawson T
    J Virol; 1988 Dec; 62(12):4712-21. PubMed ID: 2846881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
    Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratin expression and steroidogenesis in rat granulosa cells, transformed with the Kirsten-ras and SV40 oncogenes singly and in combination.
    Pan J; Kwan RW; Auersperg N
    Mol Cell Endocrinol; 1995 Aug; 112(2):231-9. PubMed ID: 7489827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.